|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07D 231/16 | |
| A61K 31/415 | |||
| A61P 25/22 | |||
| A61P 25/24 | |||
| A61P 25/18 |
| (11) | Patento numeris | 1727803 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04757266.4 |
| Europos patento paraiškos padavimo data | 2004-07-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-12-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-03-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2004/023880 |
| Data | 2004-07-21 |
| (87) | Numeris | WO 2005/103011 |
| Data | 2011-05-20 |
| (30) | Numeris | Data | Šalis |
| 555626 P | 2003-04-20 | US |
| (72) |
FRITCH, John Robert, US
CARLETON, Fiona M., US
LALLY, Edward A., US
LI, Hongmei, US
TEEGARDEN, Bradley, US
|
| (73) |
Arena Pharmaceuticals, Inc.,
6166 Nancy Ridge Drive, San Diego, CA 92121,
US
|
| (54) | PROCESSES FOR PREPARING SUBSTITUTED N-ARYL-N`-[3-(1H-PYRAZOL-5-YL)PHENYL] UREAS AND INTERMEDIATES THEREOF |
| PROCESSES FOR PREPARING SUBSTITUTED N-ARYL-N`-[3-(1H-PYRAZOL-5-YL)PHENYL] UREAS AND INTERMEDIATES THEREOF |